Exact Sciences Corp. announced the launch of Cologuard Plus, the most accurate noninvasive colorectal cancer screening test reported in studies to date. FDA-approved for average-risk patients 45+ and covered by Medicare, the Cologuard Plus test detects 95% of colorectal cancers at 94% specificity in the U.S. screening population.
The National Cancer Institute approved the following clinical research studies last month.
The U.S. Department of Health and Human Services announced that it is making sweeping revisions by cutting personnel, centralizing functions, and consolidating divisions.
The March 15 continuing resolution has gutted the Department of Defense Congressionally Directed Medical Research Program. The program’s funding was cut by 57%, compared to Fiscal Year 2024 levels—from $1.5 billion to $650 million.
Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease.
Four research institutions have partnered under the Weill Cancer Hub East
The members of the American Association for Cancer Research have elected Keith T. Flaherty, fellow of the AACR Academy, as the AACR president-elect for 2025-2026.
Paradigm Health announced on March 20 the appointment of Karen E. Knudsen to its board of directors, alongside the upcoming launch of its eSource clinical trial data application.
The Association of Cancer Center Administrators presented its inaugural ACCA Career Achievement Award to Beverly Ginsburg Cooper, managing director at the Huron Consulting Group, on March 16. Given at the CCA Annual Business Meeting in Seattle, the ACCA Career Achievement Award recognizes current members of the Association of Cancer Center Administrators or former members of the Cancer Centers Administrators Forum who have demonstrated exemplary dedication, leadership, and lasting contributions to the field of cancer administration.
